cyclosporine and Dyskeratosis Congenita, X-Linked

cyclosporine has been researched along with Dyskeratosis Congenita, X-Linked in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arnold, R; Dokal, I; Dörken, B; Hemmati, PG; le Coutre, P; Neuburger, S; Terwey, TH; Vulliamy, T; Vuong, LG	1
Armstrong, CA; Doyle, JJ; Dror, Y; Freedman, MH; Leaker, M; Saunders, FE; Verbeek, J	1
Brazzola, P; Champagne, J; Champagne, MA; Dalle, JH; Duval, M; Fournet, JC; Gauvin, F	1

Reviews

1 review(s) available for cyclosporine and Dyskeratosis Congenita, X-Linked

Article	Year
Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita. Bone marrow transplantation, 2003, Volume: 31, Issue:10 Topics: Adrenal Cortex Hormones; Adult; Child, Preschool; Cyclosporine; Dyskeratosis Congenita; Female; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Male; Stem Cell Transplantation	2003

Article

Year

Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita.

Bone marrow transplantation, 2003, Volume: 31, Issue:10

Topics: Adrenal Cortex Hormones; Adult; Child, Preschool; Cyclosporine; Dyskeratosis Congenita; Female; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Male; Stem Cell Transplantation

2003

Other Studies

2 other study(ies) available for cyclosporine and Dyskeratosis Congenita, X-Linked

Article	Year
Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita. Acta haematologica, 2010, Volume: 124, Issue:4 Topics: Antilymphocyte Serum; Cyclosporine; Dyskeratosis Congenita; Graft Rejection; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Male; Mycophenolic Acid; Transplantation Conditioning; Treatment Outcome; Vidarabine; Young Adult	2010
Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen. Bone marrow transplantation, 2005, Volume: 36, Issue:12 Topics: Adolescent; Capillaries; Cerebral Hemorrhage; Cyclosporine; Dyskeratosis Congenita; Erythrocyte Transfusion; Esophagus; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mucous Membrane; Necrosis; Platelet Transfusion; Time Factors; Transplantation Conditioning; Vascular Diseases	2005

Article

Year

Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita.

Acta haematologica, 2010, Volume: 124, Issue:4

Topics: Antilymphocyte Serum; Cyclosporine; Dyskeratosis Congenita; Graft Rejection; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Male; Mycophenolic Acid; Transplantation Conditioning; Treatment Outcome; Vidarabine; Young Adult

2010

Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen.

Bone marrow transplantation, 2005, Volume: 36, Issue:12

Topics: Adolescent; Capillaries; Cerebral Hemorrhage; Cyclosporine; Dyskeratosis Congenita; Erythrocyte Transfusion; Esophagus; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mucous Membrane; Necrosis; Platelet Transfusion; Time Factors; Transplantation Conditioning; Vascular Diseases

2005